🟠 Moderate Evidence
Most people choose their vitamin D supplement based on what sits on the pharmacy shelf: 1,000 IU, 2,000 IU, 5,000 IU, or 10,000 IU. The implicit assumption is that more is universally better, or that a single dose produces predictable results across all individuals. Neither assumption holds true. According to landmark research published in the American Journal of Clinical Nutrition, the relationship between vitamin D dose and blood levels is curvilinear—and your starting level fundamentally changes how your body responds to any given supplement.
Key takeaways
- Ten times the vitamin D dose does not produce ten times the blood level—it produces approximately 2.8 times the level, according to published dose-response data
- The same 1,000 IU supplement raises serum 25-hydroxyvitamin D by 11 ng/mL in deficient individuals (baseline 10 ng/mL) but only 5 ng/mL in those with baseline 50 ng/mL
- The body actively regulates vitamin D circulation through hepatic hydroxylation, binding protein saturation, and catabolic clearance—it is not passively accumulating the nutrient
Study at a Glance
| Primary source | American Journal of Clinical Nutrition |
| Study type | Controlled dose-response trial (Heaney et al., 2003) + community cohort analysis (Heaney et al., 2011) |
| Sample sizes | Healthy men (trial); 3,667 adults (cohort) |
| Population | Healthy adults across baseline vitamin D levels |
| Country | United States (Nebraska, community-based) |
Vitamin D Dose Response Is Non-Linear: Same Supplement, Different Results
How serum 25-hydroxyvitamin D rises per 1,000 IU daily, depending on baseline level
Source: Heaney et al., Anticancer Research, 2011 (N=3,667) | Georgian Medical Journal News
The Curvilinear Dose-Response Relationship
In a controlled study of healthy men during winter in Nebraska, researchers at Heaney and colleagues (American Journal of Clinical Nutrition, 2003) administered three doses of cholecalciferol daily: approximately 1,000 IU, 5,500 IU, and 11,000 IU. The resulting steady-state serum 25-hydroxyvitamin D levels were roughly 30 ng/mL, 60 ng/mL, and 84 ng/mL respectively. A dose that increased more than tenfold produced only a 2.8-fold increase in blood levels. This flattening is not measurement error or individual variation—it reflects active physiological regulation.
The mechanism is well understood. As serum 25(OH)D rises, the body increases hepatic hydroxylation of the vitamin, enhances binding protein saturation, and accelerates catabolic clearance. The system operates with negative feedback; the body is not passively storing vitamin D but actively determining how much remains in circulation. This explains why supplementing a person who already has adequate levels produces minimal additional benefit.
Why Your Starting Point Predicts Your Response
The practical implication emerged clearly from a larger community-based analysis. Heaney et al. (Anticancer Research, 2011) studied 3,667 adults and plotted the first derivative of the dose-response curve—essentially, how much each additional 1,000 IU moves your blood level at different starting points. The findings were striking: at a baseline of 10 ng/mL (deficient), each additional 1,000 IU/day raised serum 25(OH)D by approximately 11 ng/mL. At 30 ng/mL, the same 1,000 IU produced only an 8 ng/mL increase. At 50 ng/mL, the increment dropped to approximately 5 ng/mL. Above 70 ng/mL, the response flattened nearly to zero.
This means a 5,000 IU supplement purchased off the pharmacy shelf will have dramatically different effects depending on whether you start at 10 ng/mL (severely deficient) or 60 ng/mL (replete). The same bottle, the same daily pill, produces radically different results. For clinical practice, this underscores why serum 25(OH)D measurement before supplementation—and reassessment after dose adjustment—is essential.
Implications for Individual Supplementation Strategy
The practical takeaway is that vitamin D supplementation is not one-size-fits-all. A person with a baseline of 15 ng/mL might achieve meaningful benefit from 2,000 IU daily, whereas someone with a baseline of 55 ng/mL might see negligible change from the same dose. Conversely, a person severely deficient might require escalation beyond standard shelf doses to reach optimal levels within a reasonable timeframe. Patient-centered dosing strategies therefore require knowledge of individual baseline status, target blood level, and expected dose-response based on starting point.
Ten times the vitamin D dose does not produce ten times the blood level—it produces approximately 2.8 times the level, and responsiveness to each 1,000 IU depends entirely on your baseline serum 25(OH)D concentration.
— Heaney et al., University of Nebraska Medical Center (American Journal of Clinical Nutrition, 2003; Anticancer Research, 2011)
What this means
Frequently asked questions
Does this mean I should take a higher dose of vitamin D?
Not necessarily. A higher dose will only raise your blood level if you start low. If your baseline serum 25(OH)D is already 40–50 ng/mL or higher, additional supplementation produces minimal benefit. The key is to know your starting level before deciding on a dose. Discuss your individual baseline and target with your clinician.
Why does the body limit vitamin D accumulation?
Vitamin D is fat-soluble, and excessive accumulation can cause hypercalcaemia and tissue damage. The body actively regulates circulating 25(OH)D through increased hepatic hydroxylation, enhanced protein binding, and accelerated catabolism. This negative feedback system prevents toxic accumulation while maintaining metabolic flexibility.
Can I exceed vitamin D toxicity thresholds through food or sunlight?
Sunlight exposure and food sources rarely cause toxicity because the skin and digestive system have natural regulatory limits. Toxicity is almost exclusively a risk with high-dose supplementation (typically >10,000 IU daily sustained over months). However, supplementation above 4,000 IU daily should be discussed with a clinician and monitored with serum 25(OH)D measurement.
The vitamin D shelf is lined with options, but the dose you need is not determined by marketing or bottle size—it is determined by your starting blood level and your individual dose-response curve. As evidence-based supplementation strategies continue to evolve, the principle remains clear: measure, target, and reassess. The same IU value means different things to different people.
Source: Heaney et al., American Journal of Clinical Nutrition (2003); Heaney et al., Anticancer Research (2011)
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
